Invesco India Business Cycle Fund
Direct Plan · Growth · Invesco Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +1.73% | +1.33% | 118 of 255 |
| 1M | -1.33% | -1.86% | 104 of 254 |
| 3M | -2.75% | -2.95% | 110 of 251 |
| 6M | +12.86% | +3.51% | 41 of 251 |
| YTD | +9.37% | -0.26% | 47 of 255 |
| 1Y | +7.29% | +0.67% | 57 of 228 |
| INCEPTION | +25.77% | — | — |
Ranked among: Equity Scheme - Sectoral/ Thematic.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +6.49% | +29.23% | -13.69% | 74% | 30% |
| 6M | +10.08% | +33.09% | -13.96% | 76% | 32% |
| 1Y | +15.51% | +24.75% | +6.49% | 100% | 45% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity95.99%
- Debt0.00%
- Cash4.01%
- Other0.00%
Market Cap Split
- Large Cap46.26%
- Mid Cap24.66%
- Small Cap25.07%
- Others4.01%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 34.20 | 28.13 |
| P/B | 4.47 | 4.63 |
| Price / Sales | 4.35 | 3.29 |
| Price / Cash Flow | 22.88 | 21.12 |
| Dividend Yield (%) | 0.40 | 1.18 |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| Triparty Repo | Reverse Repo / TREPS | 6.18% | — |
| Kotak Bank | Banks | 6.03% | +0.37% |
| Axis Bank | Banks | 6.00% | +2.43% |
| Apollo Hospitals | Equity | 5.99% | +2.11% |
| DLF | Realty | 5.62% | +1.08% |
| Sai Life Sciences | Pharmaceuticals & Biotechnology | 5.25% | +0.25% |
| Aditya Infotech | Industrial Manufacturing | 5.03% | +0.39% |
| Larsen & Toubro | Construction | 4.70% | -0.04% |
| Interglobe Aviation | Transport Services | 4.22% | -0.19% |
| Prestige Estates Projects | Realty | 3.59% | -0.34% |
| Eternal | Retailing | 3.52% | -0.07% |
| BSE | Capital Markets | 3.07% | -0.17% |
| Max Healthcare Institute | Equity | 2.99% | -0.34% |
| Trent | Retailing | 2.93% | -0.27% |
| Federal Bank | Banks | 2.90% | -0.34% |
View all 37 holdings
| AU Small Finance Bank | Banks | 2.86% | -0.20% |
| Cholamandalam Investment | Finance | 2.80% | -0.39% |
| Amber Enterprises | Consumer Durables | 2.73% | -0.37% |
| Indusind Bank | Banks | 2.62% | -0.32% |
| WeWork India Management | Commercial Services & Supplies | 2.57% | -0.08% |
| Indian Hotels Company | Leisure Services | 2.50% | +0.97% |
| L&T Finance | Finance | 2.31% | -0.48% |
| Global Health | Equity | 2.19% | -0.17% |
| Krishna Institute of Medical Sciences | Equity | 2.08% | -0.02% |
| JK Cement | Cement & Cement Products | 1.78% | -0.01% |
| Max Estates | Realty | 1.69% | +0.22% |
| Sonata Software | IT - Software | 1.44% | -0.18% |
| HDFC AMC | Capital Markets | 1.38% | -0.19% |
| Glenmark Pharmaceuticals | Pharmaceuticals & Biotechnology | 1.31% | -0.07% |
| Phoenix Mills | Realty | 0.94% | +0.02% |
| Dixon Technologies | Consumer Durables | 0.86% | -0.11% |
| Timken | Industrial Products | 0.50% | +0.00% |
| Grindwell Norton | Industrial Products | 0.47% | -0.01% |
| Carborundum Universal | Industrial Products | 0.40% | +0.05% |
| Ethos | Consumer Durables | 0.37% | -0.05% |
| Bansal Wire Industries | Industrial Products | 0.35% | +0.01% |
| Net Receivables / (Payables) | Net Current Assets | -2.17% | — |
Sector Allocation · Sep 2026
View all 16 sectors
Risk Metrics
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.39 | — | Good Risk Adjusted Returns |
What is this?
Higher the value means that fund has been able to give better returns for the amount of risk taken. It helps investors understand the return of an investment compared to its risk, showing whether the returns are due to intelligent investing or simply taking on excess risk. It is calculated by subtracting the risk-free return, defined as an Indian Government Bond, from the fund's returns, and then dividing by the standard deviation of returns.
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.64 | — | Good Risk Adjusted Returns |
What is this?
The Sortino Ratio is a financial metric used to measure the risk-adjusted return of an investment. It's a modification of the Sharpe Ratio but with a key difference; it only considers downside risk (the risk of negative returns), rather than total volatility. This means it focuses on how well an investment performs relative to the volatility that leads to losses, ignoring the volatility that results in gains. The idea is that investors are primarily concerned with minimizing losses, and positive volatility is generally seen as a good thing.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Nippon India Taiwan Equity Fund
Regular Plan · IDCW option
|
+100.03% | +53.62% | — | +28.31% |
|
Nippon India Japan Equity Fund
Regular Plan · Bonus Option
|
+25.47% | +20.74% | +9.52% | +8.78% |
|
Franklin Asian Equity Fund
Regular Plan · IDCW
|
+22.19% | +18.50% | +3.91% | +3.95% |
|
Motilal Oswal Active Momentum Fund
Direct Plan · Growth
|
+21.47% | — | — | +26.74% |
|
HDFC Pharma and Healthcare Fund
Direct Plan · IDCW Option
|
+20.54% | +28.25% | — | +28.33% |
|
SBI Automotive Opportunities Fund
Direct Plan · IDCW
|
+19.23% | — | — | +9.85% |
|
HDFC Defence Fund
Regular Plan · IDCW Option
|
+19.22% | +34.05% | — | +37.54% |
|
Kotak Healthcare Fund
Regular Plan · IDCW Option
|
+18.77% | — | — | +18.35% |
|
PGIM India Healthcare Fund
Direct Plan · Direct IDCW
|
+17.66% | — | — | +9.52% |
|
HSBC India Export Opportunities Fund
Direct Plan · Growth
|
+17.38% | — | — | +7.85% |
More From Invesco Asset Management (India) Private Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Invesco India - Invesco EQQQ Nasdaq-100 ETF Fund of Fund
Direct Plan · Growth
|
+29.47% | +31.18% | — | +25.52% |
|
Invesco India - Invesco Pan European Equity Fund of Fund
Direct Plan · IDCW
|
+25.48% | +20.19% | +14.11% | +8.38% |
|
Invesco India - Invesco Global Equity Income Fund of Fund
Direct Plan · IDCW
|
+17.21% | +23.00% | +16.34% | +11.91% |
|
Invesco India Gold ETF Fund of Fund
Direct Plan · Growth
|
+14.87% | +33.74% | +23.51% | +10.66% |
|
Invesco India Gold Exchange Traded Fund
Regular Plan · Growth
|
+13.91% | +34.54% | +23.79% | +12.90% |
|
Invesco India Manufacturing Fund
Direct Plan · IDCW
|
+12.62% | — | — | +7.59% |
|
Invesco India Small Cap Fund
Direct Plan · Growth
|
+9.87% | +20.52% | +17.60% | +22.91% |
|
Invesco India Credit Risk Fund
Direct Plan · Growth
|
+7.13% | +9.37% | +8.33% | +7.29% |
|
Invesco India Arbitrage Fund
Direct Plan · Growth
|
+6.87% | +7.42% | +7.12% | +6.95% |
|
Invesco India Ultra Short Term Fund
Direct Plan · Growth
|
+6.68% | +7.31% | +6.65% | +7.33% |
About This Scheme
Investment Objective
To generate long term capital appreciation by investing predominantly in equity and equity related securities with a focus on riding business cycles through dynamic allocation between various sectors and stocks at different stages of business cycles in the economy. There is no assurance that the investment objective of the Scheme will be achieved.
Stated Asset Allocation
Equity and Equity related instruments selected on the basis of business cycle : Min 80% Max 100% Other equity and equity related instruments : Min 0% Max 20% Money Market/ Other Liquid Instruments : Min 0% Max 20% Gold / Silver ETFs : Min 0% Max 20% Units issued by InvITs : Min 0% Max 10%
Exit Load
if units are redeemed/switched out on or before 3 months from the date of allotment: 0.50% if units are redeemed/switched-out after 3 months: Nil Switch between the Plans under the Scheme: Nil
Fund Managers
Mr. Aditya Khemani
Mr. Aditya Khemani - Primary
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch